Because the oral cavity is the entrance portal and part of the gastrointestinal tract, oral manifestations occur in patients with inflammatory bowel disease (IBD). Oral manifestations of IBD manifest as a systemic complication or extraintestinal manifestation that may precede, exacerbate, or regress with changes in disease severity. Some of these manifestations are aphthous ulcers, gingivitis, periodontitis, halitosis and others. The oral cavity is one of the most affected areas in patients with CKD - 25-30% of patients. The aim of the present study is to investigate the relationship between dental health and chronic inflammatory bowel disease and the role of biomarkers in their diagnosis. For the period between December 2020 and March 2021 is conducted a systematic analysis of scientific publications in the available databases (PubMed, BioMedCentral, ScienceDirect, Scopus, Web of Science), examining the relationship between dental health and chronic inflammatory bowel disease and the role of biomarkers in their diagnosis.
Атанасова А. Биомаркери при хронично възпалително заболяване на червата - настояще и бъдеще. Варненски медицински форум, Том 9, № 2 (2020), 7-19
Атанасова А. Влиянието на miRNAs върху регулацията на имунната система при възпалителни заболявания на червата. Варненски медицински форум, Том 9, № 2 (2020), 20-32
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78
Аtanasova A. Different faces of inflammation, considered upon the expression of microRNA-155.Book of proceedings. Symposium “Alumni Club and Friends” – MU-Varna, 06-08.03.2020, 62-73
Bartlett DW, Lussi A, West NX, Bouchard P, Sanz M, Bourgeois D. Prevalence of tooth wear on buccal and lingual surfaces and possible risk factors in young European adults. J Dent 2013;41:1007-1013
Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet 2012;380:1590-605
Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 2001;59:235-43
Campbell H, Escudier M, Patel P et al. Distinguishing orofacial granulomatosis from Crohn’s disease: two separate disease entities? Inflamm Bowel Dis 2011;17: 2109–2115
Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, Hu WY, Lin SC. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res. 2008 Nov;87(11):1063-8
Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, Liu X, Zhou X. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol. 2012 Aug;48(8):686-91
Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of systemic disease. Am Fam Physician 2010 Dec 1;82(11):1381-8
Dudeney TP. Crohn’s disease of the mouth. Proc R Soc Med 1969 62: 1237
Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol 1991 18: 690–697
Grossner-Schreiber B, Fetter T, Hedderich J et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol 2006 33: 478–484
Habashneh RA, Khader YS, Alhumouz MK et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. J Periodontal Res 2012 47: 293–298
Haneklaus M, Gerlic M, O‘Neill LA, Masters SL. miR-223: infection, inflammation and cancer. J Intern Med. 2013 Sep;274(3):215-26
Hao J, Zhao S, Zhang Y, Zhao Z, Ye R, Wen J, Li J. Emerging role of microRNAs in cancer and cancer stem cells. J Cell Biochem. 2014 Apr;115(4):605-10
Harty S, Fleming P, Rowland M et al. A prospective study of the oral manifestations of Crohn’s disease. Clinical Gastroenterology Hepatology 2005; 3 (9): 886–891
Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O‘Sullivan B, Waldron J, Gullane P, Cummings B, Liu FF. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010 Feb 15;16(4):1129-39
Katsanos KH, Torres J, Roda G, Brygo A, Delaporte E, Colombel JF. Review article: nonmalignant oral manifestations in inflammatory bowel diseases. Aliment Pharmacol Ther 2015 Jul; 42(1): 40-60
Ke XF, Fang J, Wu XN, Yu CH. MicroRNA-203 accelerates apoptosis in LPS-stimulated alveolar epithelial cells by targeting PIK3CA. Biochem Biophys Res Commun. 2014 Aug 8;450(4):1297-303
Lamster IB, Rodrick ML, Sonis ST, Falchuk ZM. An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease. J Periodontol 1982;53:231-8
Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol 2013;19:8571-9
Lauritano D, Boccalari E, Stasio DD et al. Prevalence of oral lesions and correlation with intestinal symptoms of inflammatory bowel disease: a systematic review. Diagnostics (Basel) 2019 9: 77–92
Majorana A, Bardellini E, Flocchini P, Amadori F, Conti G, Campus G. Oral mucosal lesions in children from 0 to 12 years old: ten years’ experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Jul;110(1):e13-8.
Maqbool R, Ul Hussain M. MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell Tissue Res. 2014 Oct;358(1):1-15
Mayrand D, Holt SC. Biology of asaccharolytic black-pigmented Bacteroides species. Microbiol Rev. 1988 Mar;52(1):134-52
M’Koma, A.E., Inflammatory bowel disease: an expanding global health problem. Clinical medicine insights. Gastroenterology, 2013. 6: p. 33
Mulic A, Tveit AB, Skaare AB. Prevalence and severity of dental erosive wear among a group of Norwegian 18-year-olds. Acta Odontol Scand 2013;71:475-481
O‘Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010 Feb;10(2):111-22
Papageorgiou SN, Hagner M, Nogueira AV et al. Inflammatory bowel disease and oral health: systematic review and a metaanalysis. J Clin Periodontol 2017 44: 382–393
Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009 Sep 1;15(17):5473-7
Pastore L, Campisi G, Compilato D, Lo Muzio L. Orally based diagnosis of celiac disease: current perspectives. J Dent Res 2008; 87(12): 1100-7
Primo MN, Bak RO, Schibler B, Mikkelsen JG. Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes. Cytokine. 2012 Dec;60(3):741-8
Qin S, Zhang C. MicroRNAs in vascular disease. J Cardiovasc Pharmacol. 2011 Jan;57(1):8-12
Schulte LN, Westermann AJ, Vogel J. Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res. 2013 Jan 7;41(1):542-53
Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y, Bao ZX, Jiang WW. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential. Head Neck. 2015 Jul;37(7):970-6
Smith CH1, Materna A2, Martig L3, Lussi A4. Gastrooesophageal reflux is common in oligosymptomatic patients with dental erosion: A pH-impedance and endoscopic study. United European Gastroenterol J 2015 Apr;3(2):174-81
Staedel C, Darfeuille F. MicroRNAs and bacterial infection. Cell Microbiol. 2013 Sep;15(9):1496-507
Tan CX, Brand HS, de Boer NK et al. Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn’s disease. Br Dent J 2016, 221: 794–799
Tan CX, Brand HS, de Boer NK et al. Gastrointestinal diseases and their oro-dental manifestations: Part 2: ulcerative colitis. Br Dent J 2017, 222: 53–57
Tolia V. Evaluation and management of pediatric gastroesophageal reflux. Fam Pract Recert 1997;19:35-57
Van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 1986;53:671-7
Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011;106:110-9
Vavricka SR, Manser CN, Hediger S et al. Periodontitis and gingivitis in inflammatory bowel disease: a case-control study.Inflamm Bowel Dis 2013 19: 2768–2777
Xu G, Zhang Z, Wei J, Zhang Y, Zhang Y, Guo L, Liu X. microR-142-3p down-regulates IRAK-1 in response to Mycobacterium bovis BCG infection in macrophages. Tuberculosis (Edinb). 2013 Nov;93(6):606-11
